Polycystic Ovary Syndrome is a hormonal and metabolic condition affecting roughly 1 in 10 women of reproductive age. It can cause irregular cycles, acne, excess hair growth, hair thinning, weight changes, fatigue, mood changes, and fertility challenges, though symptoms vary widely from person to person.

Alaia is a digital health companion for women with PCOS. It helps you track symptoms, understand patterns, prepare for doctor appointments, and manage your condition with evidence-based tools. It is not a generic period tracker. It is built specifically for the complexity and variability of PCOS.

How is Alaia different from other PCOS apps?

Most health apps assume regular cycles and focus on fertility. Alaia starts from symptoms, supports four different cycle states including absent periods, and generates specialist-specific appointment prep reports. It also includes advocacy tools for women who are still seeking a diagnosis or have been dismissed by their doctor.

Do I need to track my cycle to use it?

No. Many women with PCOS have highly irregular or absent cycles. Alaia works just as well if you focus on symptoms, mood, energy, or medication tracking instead. Your cycle is one input, not the centre of the app.

Yes. Your data is stored securely in the EU, encrypted at rest and in transit, and belongs only to you. Alaia complies with GDPR, including health data protections under Article 9. You can export or delete your data at any time. We never sell your data.

Is Alaia a medical device?

Alaia is designed as a Class I Software as a Medical Device under EU MDR 2017/745. It is a tracking and information tool, not a diagnostic or treatment tool. We are pursuing reimbursement through public health insurance pathways in Belgium, France, and Germany.

Can I share my data with my doctor?

Yes. Alaia helps you create a clear, specialist-specific visit report you can download, email, or bring to your appointment, making it easier to discuss what has been happening and what matters most.

When can I try Alaia?

Alaia is currently in development with beta launch coming soon. Join the waitlist to be the first to get access.

Nahrungsergänzung bei PCOS: Was die Forschung wirklich sagt

Laure Santolini

Mitgründerin, Alaia

Veröffentlicht am: April 14, 2026
Lesezeit: 11 Min. Lesezeit

In Prüfung durch den wissenschaftlichen Beirat

Nahrungsergänzung ist eines der meistgesuchten Themen in PCOS-Communitys und eines der am häufigsten missverstandenen. Dieser Beitrag betrachtet die Evidenz für die häufigsten PCOS-Präparate und hilft dir, sie mit deinem Behandlungsteam zu besprechen.

Benachrichtigt werden

Sei die Erste, die den vollständigen Artikel liest

Trag dich in die Alaia-Warteliste ein und wir sagen dir Bescheid, sobald dieser Beitrag veröffentlicht ist.

Zur Warteliste →

Quellen

Teede HJ, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Fertility and Sterility, 2023.
Endocrine Society. Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab, 2013.
Unfer V, et al. Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials. Gynecological Endocrinology, 2017.